Global Prostate Cancer Screening Market Insights, Forecast to 2031

Report ID: 1655047 | Published Date: Dec 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Physical Exam
        1.2.3 Laboratory Tests
        1.2.4 Imaging Tests
        1.2.5 Gleason Score
        1.2.6 TNM Score
        1.2.7 Genetic Tests
        1.2.8 Digital Rectal Exam
        1.2.9 Biopsy
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Labs
        1.3.5 Cancer Institutes
        1.3.6 Diagnostic Centers
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate Cancer Screening Market Perspective (2017-2028)
    2.2 Prostate Cancer Screening Growth Trends by Region
        2.2.1 Prostate Cancer Screening Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate Cancer Screening Historic Market Size by Region (2017-2022)
        2.2.3 Prostate Cancer Screening Forecasted Market Size by Region (2023-2028)
    2.3 Prostate Cancer Screening Market Dynamics
        2.3.1 Prostate Cancer Screening Industry Trends
        2.3.2 Prostate Cancer Screening Market Drivers
        2.3.3 Prostate Cancer Screening Market Challenges
        2.3.4 Prostate Cancer Screening Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Screening Players by Revenue
        3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2017-2022)
        3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
    3.4 Global Prostate Cancer Screening Market Concentration Ratio
        3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2021
    3.5 Prostate Cancer Screening Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Screening Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Screening Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Screening Breakdown Data by Type
    4.1 Global Prostate Cancer Screening Historic Market Size by Type (2017-2022)
    4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Screening Breakdown Data by Application
    5.1 Global Prostate Cancer Screening Historic Market Size by Application (2017-2022)
    5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate Cancer Screening Market Size (2017-2028)
    6.2 North America Prostate Cancer Screening Market Size by Type
        6.2.1 North America Prostate Cancer Screening Market Size by Type (2017-2022)
        6.2.2 North America Prostate Cancer Screening Market Size by Type (2023-2028)
        6.2.3 North America Prostate Cancer Screening Market Share by Type (2017-2028)
    6.3 North America Prostate Cancer Screening Market Size by Application
        6.3.1 North America Prostate Cancer Screening Market Size by Application (2017-2022)
        6.3.2 North America Prostate Cancer Screening Market Size by Application (2023-2028)
        6.3.3 North America Prostate Cancer Screening Market Share by Application (2017-2028)
    6.4 North America Prostate Cancer Screening Market Size by Country
        6.4.1 North America Prostate Cancer Screening Market Size by Country (2017-2022)
        6.4.2 North America Prostate Cancer Screening Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Prostate Cancer Screening Market Size (2017-2028)
    7.2 Europe Prostate Cancer Screening Market Size by Type
        7.2.1 Europe Prostate Cancer Screening Market Size by Type (2017-2022)
        7.2.2 Europe Prostate Cancer Screening Market Size by Type (2023-2028)
        7.2.3 Europe Prostate Cancer Screening Market Share by Type (2017-2028)
    7.3 Europe Prostate Cancer Screening Market Size by Application
        7.3.1 Europe Prostate Cancer Screening Market Size by Application (2017-2022)
        7.3.2 Europe Prostate Cancer Screening Market Size by Application (2023-2028)
        7.3.3 Europe Prostate Cancer Screening Market Share by Application (2017-2028)
    7.4 Europe Prostate Cancer Screening Market Size by Country
        7.4.1 Europe Prostate Cancer Screening Market Size by Country (2017-2022)
        7.4.2 Europe Prostate Cancer Screening Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Screening Market Size (2017-2028)
    8.2 Asia-Pacific Prostate Cancer Screening Market Size by Type
        8.2.1 Asia-Pacific Prostate Cancer Screening Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Prostate Cancer Screening Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Prostate Cancer Screening Market Share by Type (2017-2028)
    8.3 Asia-Pacific Prostate Cancer Screening Market Size by Application
        8.3.1 Asia-Pacific Prostate Cancer Screening Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Prostate Cancer Screening Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Prostate Cancer Screening Market Share by Application (2017-2028)
    8.4 Asia-Pacific Prostate Cancer Screening Market Size by Region
        8.4.1 Asia-Pacific Prostate Cancer Screening Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Prostate Cancer Screening Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Prostate Cancer Screening Market Size (2017-2028)
    9.2 Latin America Prostate Cancer Screening Market Size by Type
        9.2.1 Latin America Prostate Cancer Screening Market Size by Type (2017-2022)
        9.2.2 Latin America Prostate Cancer Screening Market Size by Type (2023-2028)
        9.2.3 Latin America Prostate Cancer Screening Market Share by Type (2017-2028)
    9.3 Latin America Prostate Cancer Screening Market Size by Application
        9.3.1 Latin America Prostate Cancer Screening Market Size by Application (2017-2022)
        9.3.2 Latin America Prostate Cancer Screening Market Size by Application (2023-2028)
        9.3.3 Latin America Prostate Cancer Screening Market Share by Application (2017-2028)
    9.4 Latin America Prostate Cancer Screening Market Size by Country
        9.4.1 Latin America Prostate Cancer Screening Market Size by Country (2017-2022)
        9.4.2 Latin America Prostate Cancer Screening Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Screening Market Size (2017-2028)
    10.2 Middle East & Africa Prostate Cancer Screening Market Size by Type
        10.2.1 Middle East & Africa Prostate Cancer Screening Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Prostate Cancer Screening Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Prostate Cancer Screening Market Share by Type (2017-2028)
    10.3 Middle East & Africa Prostate Cancer Screening Market Size by Application
        10.3.1 Middle East & Africa Prostate Cancer Screening Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Prostate Cancer Screening Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Prostate Cancer Screening Market Share by Application (2017-2028)
    10.4 Middle East & Africa Prostate Cancer Screening Market Size by Country
        10.4.1 Middle East & Africa Prostate Cancer Screening Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Prostate Cancer Screening Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
        11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Almac
        11.2.1 Almac Company Details
        11.2.2 Almac Business Overview
        11.2.3 Almac Prostate Cancer Screening Introduction
        11.2.4 Almac Revenue in Prostate Cancer Screening Business (2017-2022)
        11.2.5 Almac Recent Developments
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Bayer Business Overview
        11.3.3 Bayer Prostate Cancer Screening Introduction
        11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2017-2022)
        11.3.5 Bayer Recent Developments
    11.4 Beckman Coulter
        11.4.1 Beckman Coulter Company Details
        11.4.2 Beckman Coulter Business Overview
        11.4.3 Beckman Coulter Prostate Cancer Screening Introduction
        11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2017-2022)
        11.4.5 Beckman Coulter Recent Developments
    11.5 BioméRieux
        11.5.1 BioméRieux Company Details
        11.5.2 BioméRieux Business Overview
        11.5.3 BioméRieux Prostate Cancer Screening Introduction
        11.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2017-2022)
        11.5.5 BioméRieux Recent Developments
    11.6 Genomic Health
        11.6.1 Genomic Health Company Details
        11.6.2 Genomic Health Business Overview
        11.6.3 Genomic Health Prostate Cancer Screening Introduction
        11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2017-2022)
        11.6.5 Genomic Health Recent Developments
    11.7 Mayo Clinic
        11.7.1 Mayo Clinic Company Details
        11.7.2 Mayo Clinic Business Overview
        11.7.3 Mayo Clinic Prostate Cancer Screening Introduction
        11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2017-2022)
        11.7.5 Mayo Clinic Recent Developments
    11.8 Mdxhealth
        11.8.1 Mdxhealth Company Details
        11.8.2 Mdxhealth Business Overview
        11.8.3 Mdxhealth Prostate Cancer Screening Introduction
        11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2017-2022)
        11.8.5 Mdxhealth Recent Developments
    11.9 Roche Diagnostics
        11.9.1 Roche Diagnostics Company Details
        11.9.2 Roche Diagnostics Business Overview
        11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
        11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2017-2022)
        11.9.5 Roche Diagnostics Recent Developments
    11.10 Rosetta Genomics
        11.10.1 Rosetta Genomics Company Details
        11.10.2 Rosetta Genomics Business Overview
        11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
        11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2017-2022)
        11.10.5 Rosetta Genomics Recent Developments
    11.11 Thermo Fisher Scientific
        11.11.1 Thermo Fisher Scientific Company Details
        11.11.2 Thermo Fisher Scientific Business Overview
        11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
        11.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2017-2022)
        11.11.5 Thermo Fisher Scientific Recent Developments
    11.12 Hologic
        11.12.1 Hologic Company Details
        11.12.2 Hologic Business Overview
        11.12.3 Hologic Prostate Cancer Screening Introduction
        11.12.4 Hologic Revenue in Prostate Cancer Screening Business (2017-2022)
        11.12.5 Hologic Recent Developments
    11.13 Myriad Genetics
        11.13.1 Myriad Genetics Company Details
        11.13.2 Myriad Genetics Business Overview
        11.13.3 Myriad Genetics Prostate Cancer Screening Introduction
        11.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2017-2022)
        11.13.5 Myriad Genetics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Prostate Cancer Screening Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Physical Exam
    Table 3. Key Players of Laboratory Tests
    Table 4. Key Players of Imaging Tests
    Table 5. Key Players of Gleason Score
    Table 6. Key Players of TNM Score
    Table 7. Key Players of Genetic Tests
    Table 8. Key Players of Digital Rectal Exam
    Table 9. Key Players of Biopsy
    Table 10. Global Prostate Cancer Screening Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Prostate Cancer Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Prostate Cancer Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Prostate Cancer Screening Market Share by Region (2017-2022)
    Table 14. Global Prostate Cancer Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Prostate Cancer Screening Market Share by Region (2023-2028)
    Table 16. Prostate Cancer Screening Market Trends
    Table 17. Prostate Cancer Screening Market Drivers
    Table 18. Prostate Cancer Screening Market Challenges
    Table 19. Prostate Cancer Screening Market Restraints
    Table 20. Global Prostate Cancer Screening Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Prostate Cancer Screening Revenue Share by Players (2017-2022)
    Table 22. Global Top Prostate Cancer Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2021)
    Table 23. Ranking of Global Top Prostate Cancer Screening Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Prostate Cancer Screening Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Prostate Cancer Screening Product Solution and Service
    Table 27. Date of Enter into Prostate Cancer Screening Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Prostate Cancer Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Prostate Cancer Screening Revenue Market Share by Type (2017-2022)
    Table 31. Global Prostate Cancer Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Prostate Cancer Screening Revenue Market Share by Type (2023-2028)
    Table 33. Global Prostate Cancer Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Prostate Cancer Screening Revenue Share by Application (2017-2022)
    Table 35. Global Prostate Cancer Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Prostate Cancer Screening Revenue Share by Application (2023-2028)
    Table 37. North America Prostate Cancer Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Prostate Cancer Screening Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Prostate Cancer Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Prostate Cancer Screening Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Prostate Cancer Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Prostate Cancer Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Prostate Cancer Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Prostate Cancer Screening Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Prostate Cancer Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Prostate Cancer Screening Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Prostate Cancer Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Prostate Cancer Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Prostate Cancer Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Prostate Cancer Screening Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Prostate Cancer Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Prostate Cancer Screening Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Prostate Cancer Screening Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Prostate Cancer Screening Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Prostate Cancer Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Prostate Cancer Screening Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Prostate Cancer Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Prostate Cancer Screening Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Prostate Cancer Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Prostate Cancer Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Prostate Cancer Screening Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Prostate Cancer Screening Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Prostate Cancer Screening Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Prostate Cancer Screening Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Prostate Cancer Screening Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Prostate Cancer Screening Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Abbott Laboratories Company Details
    Table 68. Abbott Laboratories Business Overview
    Table 69. Abbott Laboratories Prostate Cancer Screening Product
    Table 70. Abbott Laboratories Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 71. Abbott Laboratories Recent Developments
    Table 72. Almac Company Details
    Table 73. Almac Business Overview
    Table 74. Almac Prostate Cancer Screening Product
    Table 75. Almac Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 76. Almac Recent Developments
    Table 77. Bayer Company Details
    Table 78. Bayer Business Overview
    Table 79. Bayer Prostate Cancer Screening Product
    Table 80. Bayer Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 81. Bayer Recent Developments
    Table 82. Beckman Coulter Company Details
    Table 83. Beckman Coulter Business Overview
    Table 84. Beckman Coulter Prostate Cancer Screening Product
    Table 85. Beckman Coulter Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 86. Beckman Coulter Recent Developments
    Table 87. BioméRieux Company Details
    Table 88. BioméRieux Business Overview
    Table 89. BioméRieux Prostate Cancer Screening Product
    Table 90. BioméRieux Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 91. BioméRieux Recent Developments
    Table 92. Genomic Health Company Details
    Table 93. Genomic Health Business Overview
    Table 94. Genomic Health Prostate Cancer Screening Product
    Table 95. Genomic Health Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 96. Genomic Health Recent Developments
    Table 97. Mayo Clinic Company Details
    Table 98. Mayo Clinic Business Overview
    Table 99. Mayo Clinic Prostate Cancer Screening Product
    Table 100. Mayo Clinic Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 101. Mayo Clinic Recent Developments
    Table 102. Mdxhealth Company Details
    Table 103. Mdxhealth Business Overview
    Table 104. Mdxhealth Prostate Cancer Screening Product
    Table 105. Mdxhealth Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 106. Mdxhealth Recent Developments
    Table 107. Roche Diagnostics Company Details
    Table 108. Roche Diagnostics Business Overview
    Table 109. Roche Diagnostics Prostate Cancer Screening Product
    Table 110. Roche Diagnostics Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 111. Roche Diagnostics Recent Developments
    Table 112. Rosetta Genomics Company Details
    Table 113. Rosetta Genomics Business Overview
    Table 114. Rosetta Genomics Prostate Cancer Screening Product
    Table 115. Rosetta Genomics Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 116. Rosetta Genomics Recent Developments
    Table 117. Thermo Fisher Scientific Company Details
    Table 118. Thermo Fisher Scientific Business Overview
    Table 119. Thermo Fisher Scientific Prostate Cancer Screening Product
    Table 120. Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 121. Thermo Fisher Scientific Recent Developments
    Table 122. Hologic Company Details
    Table 123. Hologic Business Overview
    Table 124. Hologic Prostate Cancer Screening Product
    Table 125. Hologic Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 126. Hologic Recent Developments
    Table 127. Myriad Genetics Company Details
    Table 128. Myriad Genetics Business Overview
    Table 129. Myriad Genetics Prostate Cancer Screening Product
    Table 130. Myriad Genetics Revenue in Prostate Cancer Screening Business (2017-2022) & (US$ Million)
    Table 131. Myriad Genetics Recent Developments
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Screening Market Share by Type: 2021 VS 2028
    Figure 2. Physical Exam Features
    Figure 3. Laboratory Tests Features
    Figure 4. Imaging Tests Features
    Figure 5. Gleason Score Features
    Figure 6. TNM Score Features
    Figure 7. Genetic Tests Features
    Figure 8. Digital Rectal Exam Features
    Figure 9. Biopsy Features
    Figure 10. Global Prostate Cancer Screening Market Share by Application: 2021 VS 2028
    Figure 11. Hospitals Case Studies
    Figure 12. Clinics Case Studies
    Figure 13. Research Labs Case Studies
    Figure 14. Cancer Institutes Case Studies
    Figure 15. Diagnostic Centers Case Studies
    Figure 16. Others Case Studies
    Figure 17. Prostate Cancer Screening Report Years Considered
    Figure 18. Global Prostate Cancer Screening Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global Prostate Cancer Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Prostate Cancer Screening Market Share by Region: 2021 VS 2028
    Figure 21. Global Prostate Cancer Screening Market Share by Players in 2021
    Figure 22. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2021
    Figure 24. North America Prostate Cancer Screening Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. North America Prostate Cancer Screening Market Size Market Share by Type (2017-2028)
    Figure 26. North America Prostate Cancer Screening Market Size Market Share by Application (2017-2028)
    Figure 27. North America Prostate Cancer Screening Market Size Share by Country (2017-2028)
    Figure 28. United States Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Canada Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Europe Prostate Cancer Screening Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Europe Prostate Cancer Screening Market Size Market Share by Type (2017-2028)
    Figure 32. Europe Prostate Cancer Screening Market Size Market Share by Application (2017-2028)
    Figure 33. Europe Prostate Cancer Screening Market Size Share by Country (2017-2028)
    Figure 34. Germany Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. France Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. U.K. Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Italy Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Russia Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Nordic Countries Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Prostate Cancer Screening Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Asia Pacific Prostate Cancer Screening Market Size Market Share by Type (2017-2028)
    Figure 42. Asia Pacific Prostate Cancer Screening Market Size Market Share by Application (2017-2028)
    Figure 43. Asia Pacific Prostate Cancer Screening Market Size Share by Region (2017-2028)
    Figure 44. China Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Japan Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. South Korea Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Southeast Asia Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. India Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Australia Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 50. Latin America Prostate Cancer Screening Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Latin America Prostate Cancer Screening Market Size Market Share by Type (2017-2028)
    Figure 52. Latin America Prostate Cancer Screening Market Size Market Share by Application (2017-2028)
    Figure 53. Latin America Prostate Cancer Screening Market Size Share by Country (2017-2028)
    Figure 54. Mexico Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Brazil Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Middle East & Africa Prostate Cancer Screening Market Size YoY (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Prostate Cancer Screening Market Size Market Share by Type (2017-2028)
    Figure 58. Middle East and Africa Prostate Cancer Screening Market Size Market Share by Application (2017-2028)
    Figure 59. Middle East and Africa Prostate Cancer Screening Market Size Share by Country (2017-2028)
    Figure 60. Turkey Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Saudi Arabia Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. UAE Prostate Cancer Screening Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 64. Almac Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 65. Bayer Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 66. Beckman Coulter Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 67. BioméRieux Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 68. Genomic Health Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 69. Mayo Clinic Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 70. Mdxhealth Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 71. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 72. Rosetta Genomics Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 73. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 74. Hologic Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 75. Myriad Genetics Revenue Growth Rate in Prostate Cancer Screening Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Frequently Asked Questions
Prostate Cancer Screening report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Screening report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Screening report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports